|
|
 |
|
Viewing report
|
|
|
|
Bladder Cancer Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Oct 2010, Pages: 580
This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 62 companies including many key and niche players such as Affitech A/S, Allergan, Inc., Allos Therapeutics, Inc., Astellas Pharma, Inc., Astrazeneca Plc, AVI BioPharma, Inc., BioCancell Therapeutics, Inc., Bioniche Life Sciences, Inc., Bristol-Myers Squibb Company, Celldex Therapeutics, Inc., Cytavis BioPharma GMBH, Eli Lilly and Company, Endo Pharmaceuticals Holdings, Inc., ENKAM Pharmaceuticals A/S, F. Hoffmann-La Roche Ltd., Halozyme Therapeutics, Inc., Laboratoires Pierre Fabre SA, NatImmune A/S, Oncogenex Pharmaceuticals, Inc., OncoTherapy Science, Inc., Sanofi-Aventis, Spectrum Pharmaceuticals, Inc., Telormedix SA, and Viventia Biotechnologies, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Pancreatic Cancer Drugs - Global Strategic Business Report
Prostate Cancer Therapeutics - Global Strategic Business Report
Melanoma Therapeutics - Global Strategic Business Report
Cystic Fibrosis - Global Strategic Business Report
Liver Cancer Drugs - Global Strategic Business Report
Lymphoma Therapeutics - Global Strategic Business Report
Lung Cancer Therapeutics - Global Strategic Business Report
Prescription Drugs - Global Strategic Business Report
Bipolar Disorder - Global Strategic Business Report
Tuberculosis Therapeutics - Global Strategic Business Report
|
|
|
|
